FDA Says It Approves Merck's (NYSE: MRK) Belzutifan For Cancers Associated With Von Hippel-lindau Disease
https://www.streetinsider.com/Corporate+News/FDA+Says+It+Approves+Mercks+%28MRK%29+Belzutifan+For+Cancers+Associated+With+Von+Hippel-lindau+Disease+-+Reuters+News/18815068.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.